A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration
1. 系统已在2026-10-05 10:45:27对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1097/00003246-199910000-00026 [极速查看全文]
文献链接: https://www.ovid.com/00003246-199910000-00026
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: John H. Reeves; Alison R. Cumming; Leanne Gallagher; Jennifer L. O'Brien; John D. Santamaria

